Basal Cell Carcinoma (BCC) ICD-10: C44.91
Often searched as: pearly bump on face, shiny bump on nose or ear, skin sore that won't heal, translucent bump skin, sore that keeps scabbing over, pink bump with blood vessels, skin cancer on face, most common skin cancer…
Clinical urgency level
Systems Affected
Severity Levels
mild
Small (<2cm), nodular or superficial BCC on a low-risk site (trunk, extremities) — highly curable with standard excision or topical treatment (imiquimod, PDT).
moderate
Larger lesion, high-risk location (nose, ear, eyelid, temple, scalp), or recurrent BCC — requires Mohs micrographic surgery for maximum cure and tissue preservation.
severe
Locally advanced BCC invading deep tissues (muscle, bone, cartilage), or rare metastatic BCC — requires hedgehog pathway inhibitors (vismodegib, sonidegib) and multidisciplinary oncologic care.
Red Flags
- A pearly or shiny bump on the face, ear, or scalp that is slowly growing
- A sore that bleeds, forms a scab, heals, then bleeds again repeatedly
- A flat, scar-like lesion on the face with no known history of injury (morpheaform BCC — subtle but aggressive)
- Rapid growth of a previously known skin lesion
- Lesion near the eye, nose, or ear — risk of deep invasion affecting function
- Pink waxy bump with visible blood vessels on the surface (classic nodular BCC)
Clinical Presentation
Nodular basal cell carcinoma — pearly translucent papule with telangiectasia on the nose
Source: Wikimedia Commons (CC BY-SA 3.0 )
Basal cell carcinoma image gallery — DermNet NZ
View gallery on DermNet NZ (image gallery reference)When to See a Doctor
See a dermatologist promptly for any non-healing sore, pearly bump, or growing translucent lesion on the face, ears, scalp, or neck — especially with a history of significant sun exposure. BCC is the most common cancer in humans but is almost always curable when treated early. Never ignore a spot that keeps coming back after healing.
Differential Diagnosis
- Squamous cell carcinoma (less pearly, more scaly/ulcerated — biopsy key)
- Sebaceous hyperplasia (central pore, yellowish — benign oil gland)
- Intradermal nevus (flesh-colored papule — no blood vessels, stable)
- Actinic keratosis (rough, scaly — precancerous SCC precursor)
- Scar tissue (morpheaform BCC mimic — history of trauma helps)
- Merkel cell carcinoma (rare, aggressive — firm, red-purple, grows fast)
Comorbidities
- Actinic keratosis (field cancerization — same UV damage origin)
- Previous BCC or SCC (highest risk factor for new BCC)
- Xeroderma pigmentosum (rare — extreme UV sensitivity)
- Gorlin syndrome (Basal Cell Nevus Syndrome — multiple BCCs from early age)
- Immunosuppression (transplant, HIV — higher BCC risk and more aggressive behavior)
- Albinism
Prognosis
BCC has a cure rate exceeding 95% when treated early and appropriately. Mohs micrographic surgery achieves the highest cure rates (99% for primary BCC) with maximum tissue preservation — ideal for facial lesions. Topical treatments (imiquimod, 5-FU) and photodynamic therapy (PDT) are effective for superficial BCC. BCC virtually never metastasizes, but locally advanced cases can cause significant tissue destruction, disfigurement, and functional impairment. Lifelong annual skin checks are essential as the risk of new BCCs remains elevated.
Detailed Overview
Tags

Analyze your skin and hair with AI
Instantly analyze your skin with AI and get personal recommendations.
- - Get instant skin analysis
- - Personalized results from AI

* The scan result is not a diagnosis. To obtain a diagnosis and a treatment recommendation, consult your doctor.
Explore more conditions
Learn about other skin and hair conditions.